The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts.
Open accessAbstract
Increased expression of wild-type p53 in response to DNA damage arrests cells late in the G1 stage of the cell cycle by stimulating the synthesis of inhibitors of cyclin-dependent kinases, such as p21/WAF1. To study the effects of p53 without the complication of DNA damage, we used tetracycline to regulate its expression in MDAH041 human fibroblasts that lack endogenous p53. When p53 is expressed at a level comparable to that induced by DNA damage in other cells, most MDAH041 cells arrested in G1, but a significant fraction also arrested in G2/M. Cells released from a mimosine block early in S phase stopped predominantly in G2/M in the presence of p53, confirming that p53 can mediate arrest at this stage, as well as in G1. In these cells, there was appreciable induction of p21/WAF1. MDAH041 cells arrested by tetracycline-regulated p53 for as long as 20 days resumed growth when the p53 level was lowered, in striking contrast to the irreversible arrest mediated by DNA damage. Therefore, irreversible arrest must involve processes other than or in addition to the interaction of p53-induced p21/WAF1 with G1 and G2 cyclin-dependent kinases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“P53 uses cell cycle checkpoints to induce G1/S142, 143 and G2/M cell cycle arrest.144”
From Census and evaluation of p53 target genes (2017) · cites this paper as [144]
Citations
Cites
Antibodies, a laboratory manual
(1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90130-3 · Cited by 12,318
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
Lane, D. P. (1992) · Nature · doi:10.1038/358015a0 · Cited by 5,138
Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.
Gossen, M., & Bujard, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5547 · Cited by 4,943
Participation of p53 protein in the cellular response to DNA damage.
Kastan, M. B., Onyekwere, O. C., Sidransky, D., Vogelstein, B., & Craig, R. W. (1991) · PubMed · Cited by 3,761
p21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,691
Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.
Greenblatt, M. S., Bennett, W. P., Hollstein, M., & Harris, C. C. (1994) · PubMed · Cited by 3,463
p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
Lowe, S. W., Ruley, H. E., Jacks, T., & Housman, D. E. (1993) · Cell · doi:10.1016/0092-8674(93)90719-7 · Cited by 2,911
Cited by
Sorted by citations
Items 201–300 of 856
Deng, J., Zhong, Y.-F., Wu, Y.-P., Luo, Z., Sun, Y.-M., Wang, G.-E., Kurihara, H., Li, Y.-F., & He, R. (2017) · Redox Biology · doi:10.1016/j.redox.2017.08.003 · Cited by 90
Dunkern, T. R., & Kaina, B. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.01-05-0225 · Cited by 90
Zheng, F., Tang, Q., Wu, J., Zhao, S., Liang, Z., Li, L., Wu, W., & Hann, S. S. (2014) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-33-36 · Cited by 90
Lai, P. B. S., Chi, T., & Chen, G. G. (2006) · APOPTOSIS · doi:10.1007/s10495-006-0571-1 · Cited by 89
Integrative radiation carcinogenesis: interactions between cell and tissue responses to DNA damage
Barcellos‐Hoff, M. H. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2004.08.010 · Cited by 88
RNF6 Promotes Colorectal Cancer by Activating the Wnt/β-Catenin Pathway via Ubiquitination of TLE3
Liu, L., Zhang, Y., Wong, C. C., Zhang, J., Dong, Y., Li, X., Kang, W., Chan, F. K. L., Sung, J. J. �., & Yu, J. Q. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-2683 · Cited by 89
Effect of Intragastric Application ofN-Methylnitrosourea inp53 Knockout Mice
Ohgaki, H., Fukuda, M., Tohma, Y., Huang, H., Stoica, G., Tatematsu, M., & Donehower, L. A. (2000) · Molecular Carcinogenesis · doi:10.1002/1098-2744(200006)28:2 · Cited by 22
Identification of a Functional Domain in a GADD45-mediated G2/M Checkpoint
Yang, Q., Manicone, A. M., Coursen, J. D., Linke, S. P., Nagashima, M., Forgues, M., & Wang, X. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005319200 · Cited by 86
The novel trinuclear platinum complex BBR3464 induces a cellular response different from cisplatin
Servidei, T., Ferlini, C., Riccardi, A., Meco, D., Scambia, G., Segni, G., Manzotti, C., & Riccardi, R. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00061-2 · Cited by 86
Heritability of cervical tumours
Magnusson, P. K. E., Lichtenstein, P., & Gyllensten, U. B. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20001201)88:5 · Cited by 179
Therapeutic Exploitation of Checkpoint Defects in Cancer Cells Lacking p53 Function
Dixon, H., & Norbury, C. J. (2002) · Cell Cycle · doi:10.4161/cc.1.6.257 · Cited by 85
Modulation of RNA Polymerase Assembly Dynamics in Transcriptional Regulation
Gorski, S. A., Snyder, S. K., John, S., Grummt, I., & Misteli, T. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.04.021 · Cited by 85
Qin, J.-L., Shen, W., Chen, Z., Zhao, L., Qin, Q., Yu, Y.-C., & Liang, H. (2017) · Scientific Reports · doi:10.1038/srep46056 · Cited by 87
Cao, X., Wang, A., Jiao, R.-Z., Wang, C. L., Mao, D.-Z., Yan, L., & Zeng, B. (2009) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-009-9065-4 · Cited by 84
Expression and Prognostic Role of Cyclin-Dependent Kinase 1 (cdc2) in Hepatocellular Carcinoma
Ito, Y., Takeda, T., Sakon, M., Monden, M., Tsujimoto, M., & Matsuura∥, N. (2000) · Oncology · doi:10.1159/000012140 · Cited by 84
Synthetically lethal nanoparticles for treatment of endometrial cancer
Ebeid, K., Meng, X., Thiel, K. W., Do, A., Geary, S. M., Morris, A. S., Pham, E. L., Wongrakpanich, A., Chhonker, Y. S., Murry, D. J., et al. (2017) · Nature Nanotechnology · doi:10.1038/s41565-017-0009-7 · Cited by 82
Badie, C., Itzhaki, J. E., Sullivan, M. J., Carpenter, A. J., & Porter, A. C. G. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.7.2358-2366.2000 · Cited by 83
B-MYB Is Required for Recovery from the DNA Damage–Induced G2 Checkpoint in p53 Mutant Cells
Mannefeld, M., Klassen, E., & Gaubatz, S. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4156 · Cited by 82
p53--An Acrobat in Tumorigenesis
Moll, U. M., & Schramm, L. (1998) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/10454411980090010101 · Cited by 81
Distinct phosphatases antagonize the p53 response in different phases of the cell cycle
Shaltiël, I. A., Aprelia, M., Saurin, A. T., Chowdhury, D., Kops, G. J. P. L., Voest, E. E., & Medema, R. H. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1322021111 · Cited by 82
p53 and Brain Tumors: From Gene Mutations to Gene Therapy
Fulci, G., Ishii, N., & Meir, E. G. V. (1998) · Brain Pathology · doi:10.1111/j.1750-3639.1998.tb00187.x · Cited by 79
p53 inhibits entry into mitosis when DNA synthesis is blocked
Taylor, W. R., Agarwal, M. L., Agarwal, A. M., Stacey, D. W., & Stark, G. R. (1999) · Oncogene · doi:10.1038/sj.onc.1202516 · Cited by 81
Self-citationKim, J., Kim, E. J., Oh, J. S., Park, I., & Hwang, S. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0888 · Cited by 79
Fitch, M. E. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg031 · Cited by 81
Becker, E., & Richardson, D. R. (1999) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(99)90173-7 · Cited by 79
p53 in Tumor Progression: Life, Death, and Everything
Mowat, M. R. A. (1998) · Advances in cancer research · doi:10.1016/s0065-230x(08)60764-2 · Cited by 78
Carlisle, D. L. (2000) · Toxicological Sciences · doi:10.1093/toxsci/55.1.60 · Cited by 78
Turner, J. (2005) · Blood · doi:10.1182/blood-2005-03-1263 · Cited by 80
Sadler, J. B. A., Wenzel, D. M., Strohacker, L. K., Guindo-Martínez, M., Alam, S. L., Mercader, J. M., Torrents, D., Ullman, K. S., Sundquist, W. I., & Martin‐Serrano, J. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1805504115 · Cited by 76
Han, C. L., Demetris, J. A., Michalopoulos, G. K., Zhan, Q., Shelhamer, J. H., & Wu, T. (2003) · Hepatology · doi:10.1053/jhep.2003.50296 · Cited by 76
Bower, J. J., Vance, L. D., Psioda, M., Smith-Roe, S. L., Simpson, D. A., Ibrahim, J. G., Hoadley, K. A., Perou, C. M., & Kaufmann, W. K. (2017) · npj Breast Cancer · doi:10.1038/s41523-017-0009-7 · Cited by 76
Overexpression of c-Myc Alters G 1 /S Arrest following Ionizing Radiation
Sheen, J.-H., & Dickson, R. B. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.6.1819-1833.2002 · Cited by 76
Overexpression of Sp1 leads to p53‐dependent apoptosis in cancer cells
Chuang, J., Wu, C., Lai, M., Chang, W., & Hung, J. (2009) · International Journal of Cancer · doi:10.1002/ijc.24563 · Cited by 75
BLIMP1 regulates cell growth through repression of p53 transcription
Yan, J., Jiang, J., Lim, C. A., Wu, Q., Ng, H., & Chin, K.-C. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605562104 · Cited by 75
McKenzie, P., Guichard, S. M., Middlemas, D. S., Ashmun, R. A., Danks, M. K., & Harris, L. C. (1999) · PubMed · Cited by 75
Sjöblom, T., West, A., & Lähdetie, J. (1998) · Environmental and Molecular Mutagenesis · doi:10.1002/(sici)1098-2280(1998)31:2 · Cited by 74
Tumor suppressor p53 links ceramide metabolism to DNA damage response through alkaline ceramidase 2
Xu, R., Garcı́a-Barros, M., Wen, S., Li, F., Lin, C., Hannun, Y. A., Obeid, L. M., & Mao, C. (2017) · Cell Death and Differentiation · doi:10.1038/s41418-017-0018-y · Cited by 73
Ho, D. Y., McLaughlin, J. R., & Sapolsky, R. M. (1996) · Molecular Brain Research · doi:10.1016/0169-328x(96)00097-6 · Cited by 73
Hanna, D. H., & Saad, G. R. (2020) · RSC Advances · doi:10.1039/d0ra03719b · Cited by 72
RetractedEffects of p 53 mutations on apoptosis in mouse intestinal and human colonic adenomas
Fazeli, A., Steen, R. G., Dickinson, S., Bautista, D., Dietrich, W. F., Bronson, R. T., Bresalier, R. S., Lander, E. S., Costa, J. C., & Weinberg, R. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.19.10199 · Cited by 73
Friedreich?s ataxia: iron chelators that target the mitochondrion as a therapeutic strategy?
Richardson, D. R. (2003) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.12.2.235 · Cited by 71
Kamei, J., Toyofuku, T., & Hori, M. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.10.129 · Cited by 71
Choi, H., Chung, T., Kang, S., Lee, Y., Ko, J., Kim, J.-G., & Kim, C. (2006) · Glycobiology · doi:10.1093/glycob/cwj105 · Cited by 71
Wang, Y., Han, A., Chen, E., SINGH, R. K., Chichester, C. O., Moore, R. G., SINGH, A. P., & Vorsa, N. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.2931 · Cited by 70
Gupta, M., Fan, S., Zhan, Q., Kohn, K. W., O'Connor, P. M., & Pommier, Y. G. (1997) · PubMed · Cited by 69
Mutant p53 Forms a Complex with Sp1 on HIV-LTR DNA
Chicas, A., Molina, P. E., & Bargonetti, J. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3965 · Cited by 69
Lowery, C. D., VanWye, A. B., Dowless, M. S., Blosser, W. D., Falcón, B. L., Stewart, J. A., Stephens, J. R., Beckmann, R. P., Bence, A. K., & Stancato, L. F. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2876 · Cited by 69
Roles of p53 and Caspases in the Induction of Cell Cycle Arrest and Apoptosis by HIV-1 vpr
Shostak, L. D., Ludlow, J. W., Fisk, J., Pursell, S., Rimel, B. J., Nguyen, D. X., Rosenblatt, J. D., & Planelles, V. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4568 · Cited by 69
DNA Damage Triggers p21WAF1-dependent Emi1 Down-Regulation That Maintains G2 Arrest
Lee, J., Kim, J. A., Barbier, V., Fotedar, A., & Fotedar, R. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-08-0818 · Cited by 68
Amin, A. R. M. R., Paul, R. K., Thakur, V. S., & Agarwal, M. L. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0655 · Cited by 68
Self-citationGrowth inhibitory effects of quercetin on bladder cancer cell
Ma, L. (2006) · Frontiers in bioscience · doi:10.2741/1970 · Cited by 68
Schwartz, D., Goldfinger, N., Kam, Z., & Rotter, V. (1999) · PubMed · Cited by 68
Significance of the Response of Quiescent Cell Populations within Solid Tumors in Cancer Therapy
Masunaga, S., & Ono, K. (2002) · Journal of Radiation Research · doi:10.1269/jrr.43.11 · Cited by 68
Metformin limits ceramide-induced senescence in C2C12 myoblasts
Jadhav, K. S., Dungan, C. M., & Williamson, D. L. (2013) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2013.11.002 · Cited by 67
Kuganesan, N., Dlamini, S., Tillekeratne, L. M. V., & Taylor, W. R. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101365 · Cited by 71
Self-citationRao, B., Laı́n, S., & Thompson, A. M. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.702 · Cited by 66
Revy, P., Buck, D., Deist, F. L., & de Villartay, J. (2005) · Advances in immunology · doi:10.1016/s0065-2776(05)87007-5 · Cited by 70
Mirza, S., Sharma, G., Pandya, P., & Ralhan, R. (2010) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-010-0473-y · Cited by 65
Activation of p53-mediated cell cycle checkpoint in response to micronuclei formation
Sablina, A. A., Ilyinskaya, G. V., Rubtsova, S. N., Agapova, L. S., Chumakov, P. M., & Kopnin, B. P. (1998) · Journal of Cell Science · doi:10.1242/jcs.111.7.977 · Cited by 64
Radiosensitisation of human colorectal cancer cells by ruthenium(II) arene anticancer complexes
Carter, R., Westhorpe, A., Romero, M., Habtemariam, A., Gallevo, C., Bark, Y., Menezes, N., Sadler, P. J., & Sharma, R. (2016) · Scientific Reports · doi:10.1038/srep20596 · Cited by 63
Kim, J., Choi, J., Kim, T., Yoo, Y., Kim, J., Lee, Y. J., Yoo, S., Cho, C.-K., Lee, Y., & Lee, S. (2001) · Journal of Cellular Physiology · doi:10.1002/jcp.10049 · Cited by 63
McKay, B. C., Chen, F., Clarke, S. T., Wiggin, H. E., Harley, L. M., & Ljungman, M. E. (2001) · Mutation Research/DNA Repair · doi:10.1016/s0921-8777(00)00064-1 · Cited by 63
Mimosine Arrests Cells in G1 by Enhancing the Levels of p27Kip1
Wang, G. G., Miskimins, R., & Miskimins, W. K. (2000) · Experimental Cell Research · doi:10.1006/excr.1999.4743 · Cited by 63
Miao, H., Seiler, J. A., & Burhans, W. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m204264200 · Cited by 60
Ito, K., Nakazato, T., Miyakawa, Y., Yamato, K., Ikeda, Y., & Kizaki, M. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10289 · Cited by 62
Agarwal, M. K., Hastak, K., Jackson, M. W., Breit, S. N., Stark, G. R., & Agarwal, M. L. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607210103 · Cited by 62
Self-citationChernova, O. B., Chernov, M. V., Ishizaka, Y., Agarwal, M. L., & Stark, G. R. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.1.536 · Cited by 62
Self-citationBean, L. J., & Stark, G. R. (2001) · Oncogene · doi:10.1038/sj.onc.1204204 · Cited by 63
Self-citationFournier, C., Wiese, C., & Taucher-Scholz, G. (2004) · Radiation Research · doi:10.1667/rr3182 · Cited by 61
CyclinG Contributes to G2/M Arrest of Cells in Response to DNA Damage
Shimizu, A., Nishida, J., Ueoka, Y., Kato, K., Hachiya, T., Kuriaki, Y., & Wake, N. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.8004 · Cited by 61
Hsu, S., Chen, M., Chou, Y.-H., Hwang, G., & Yin, S. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4397 · Cited by 61
Wallace, N. A., Robinson, K. L., & Galloway, D. A. (2014) · Journal of Virology · doi:10.1128/jvi.03808-13 · Cited by 57
Chen, L., Li, J., Fan, Y., Qiu, J., Cao, L., Laurent, R., Mignani, S. M., Caminade, A., Majoral, J., & Shi, X. (2020) · Biomacromolecules · doi:10.1021/acs.biomac.0c00458 · Cited by 61
Kim (1992) · International Journal of Oncology · doi:10.3892/ijo_00000032 · Cited by 59
KMTase Set7/9 is a critical regulator of E2F1 activity upon genotoxic stress
Lezina, L., Aksenova, V., Ivanova, T., Purmessur, N. S., Antonov, A. V., Tentler, D., Fedorova, O., Garabadgiu, A. V., Talianidis, I., Melino, G., et al. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.108 · Cited by 58
A three‐dimensional skin equivalent reflecting some aspects of in vivo aged skin
Diekmann, J., Alili, L., Scholz, O., Giesen, M., Holtkötter, O., & Brenneisen, P. (2015) · Experimental Dermatology · doi:10.1111/exd.12866 · Cited by 60
Walker, A. M., & Stevens, J. J. (2016) · Journal of Cancer Science & Therapy · doi:10.4172/1948-5956.1000379 · Cited by 59
Mdm2 Is Required for Survival and Growth of p53-Deficient Cancer Cells
Feeley, K. P., Adams, C. M., Mitra, R., & Eischen, C. M. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0809 · Cited by 57
MONITORING HUMAN RADIATION EXPOSURE BY GENE EXPRESSION PROFILING: POSSIBILITIES AND PITFALLS
Amundson, S. A., & Fornace, A. J. (2003) · Health Physics · doi:10.1097/00004032-200307000-00009 · Cited by 59
Li, C., Lin, M., & Liu, J. (2004) · Oncogene · doi:10.1038/sj.onc.1208114 · Cited by 58
Nazari, M., Ghorbani, A., Hekmatdoost, A., Jeddi‐Tehrani, M., & Zand, H. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.10.053 · Cited by 58
Hsu, H., Huang, R.-F. S., Kao, T.-H., Inbaraj, B. S., & Chen, B. (2017) · Nanotechnology · doi:10.1088/1361-6528/aa5e86 · Cited by 59
Meena, R., Kumar, S. R., Kumar, R., Gaharwar, U. S., & Rajamani, P. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.07.151 · Cited by 58
In Vivo and In Vitro Suppression of Hepatocellular Carcinoma by EF24, a Curcumin Analog
Liu, H., Liang, Y., Wang, L., Tian, L., Song, R., Han, T., Pan, S., & Liu, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048075 · Cited by 57
Nuñez-Hernandez, D. M., Félix-Portillo, M., Peregrino-Uriarte, A. B., & Yepiz-Plascencia, G. M. (2017) · Chemosphere · doi:10.1016/j.chemosphere.2017.09.131 · Cited by 58
Testicular germ cell tumours: The paradigm of chemo-sensitive solid tumours
di Pietro, A., de Vries, E. G. E., Gietema, J. A., Spierings, D. C. J., & de Jong, S. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.06.014 · Cited by 57
Bucci, B., D’Agnano, I., Amendola, D., Citti, A., Raza, G. H., Miceli, R., Paula, U. D., Marchese, R., Albini, S., Felsani, A., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1582 · Cited by 57
Takahashi, A. (2001) · International Journal of Radiation Biology · doi:10.1080/09553000010009495 · Cited by 57
A comprehensive study of p53 protein
Patil, M. R., & Bihari, A. (2022) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30331 · Cited by 57
Weiss, M. B., Vitolo, M. I., Mohseni, M., Rosen, D. M., Denmeade, S. R., Park, B. H., Weber, D. J., & Bachman, K. E. (2010) · Oncogene · doi:10.1038/onc.2010.220 · Cited by 54
Deng, Z., Manz, D. H., Torti, S. V., & Torti, F. M. (2017) · Oncotarget · doi:10.18632/oncotarget.19288 · Cited by 58
Potential of the Flavonoid Quercetin to Prevent and Treat Cancer – Current Status of Research
Neuwirthová, J., Gál, B., Smilek, P., & Urbánková, P. (2018) · Klinicka onkologie · doi:10.14735/amko2018184 · Cited by 56
Jo, H. J., Song, J., Kim, K., Cho, Y. H., Kim, K., & Park, Y. (2008) · Oncology Reports · doi:10.3892/or.19.1.275 · Cited by 56
Induction of p53-dependent and p53-independent cellular responses by topoisomerase 1 inhibitors
McDonald, A. C., & Brown, R. E. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.571 · Cited by 56
Huang, J., Shui, K.-J., Li, H., Hu, M., & Zhong, G. (2010) · Pesticide Biochemistry and Physiology · doi:10.1016/j.pestbp.2010.08.002 · Cited by 55
Integrin α6 mediates the drug resistance of acute lymphoblastic B-cell leukemia
Gang, E. J., Kim, H. N., Hsieh, Y., Ruan, Y., Ogana, H. A. N., Lee, S., Pham, J., Geng, H., Park, E., Klemm, L., et al. (2020) · Blood · doi:10.1182/blood.2019001417 · Cited by 55
Park, J. G., Aziz, N., & Cho, J. Y. (2019) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835919875574 · Cited by 57
MECHANISMS OF CELL-CYCLE CHECKPOINTS: AT THE CROSSROADS OF CARCINOGENESIS AND DRUG DISCOVERY*
Flatt, P. M., & Pietenpol, J. A. (2000) · Drug Metabolism Reviews · doi:10.1081/dmr-100102335 · Cited by 54
Smith‐Sørensen, B., Kærn, J., Holm, R., Dørum, A., Trope, C. G., & Børresen‐Dale, A. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.502 · Cited by 54
Arsenite Disrupts Mitosis and Induces Apoptosis in SV40-Transformed Human Skin Fibroblasts
States, J. C., Reiners, J. J., Pounds, J. G., Kaplan, D. J., Beauerle, B. D., McNeely, S., Mathieu, P., & McCabe, M. J. (2002) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2002.9376 · Cited by 53
Metadata
- Authors
- Agarwal, M. L., Agarwal, A., Taylor, W. R., & Stark, G. R.
- Affiliations
- Cleveland Clinic (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 1995-08-29
- Volume
- 92
- Issue
- 18
- Pages
- 8493-8497
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC41183
- OpenAlex
- W2016492849
- Semantic Scholar
- 0dec4b0f37cb7f12a6b4023ec829754468df3935
- Cited by
- 858
- References
- 30
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 13 · 2023: 22 · 2022: 12 · 2021: 18 · 2020: 24 · 2019: 21 · 2018: 22 · 2017: 40 · 2016: 29 · 2015: 28 · 2014: 33 · 2013: 25 · 2012: 25
- FWCI
- 17.64
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Keywords
- p53, G2/M checkpoint, G1/S checkpoint, cell cycle arrest, p21, cyclin-dependent kinases, mimosine, DNA damage response
- MeSH terms
- Cell Cycle, Cell Division, Cell Line, Fibroblasts, Gene Expression Regulation, Humans, Genes, p53, Cyclins, Cyclin-Dependent Kinase Inhibitor p21
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review